GE HealthCare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. Explore more ...

U.S. forest managers have finalized a land exchange with the Yavapai-Apache Nation that has been decades in the making and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Siemens Healthineers AG (SEMHF – Research Report) and ...

UBS analyst Graham Doyle maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of ...

Siemens Healthineers met its annual revenue and profit growth forecast on Wednesday, as strength in its Imaging segment and U.S. cancer treatment unit Varian in the fourth quarter outweighed weakness ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

Wide-moat Siemens Healthineers reported solid fourth-quarter fiscal 2024 results with revenue reaching EUR 6.3 billion, comparable growth of 5.6%. Investors responded positively with shares rising ...

The healthcare company met annual targets despite posting lower-than-expected fourth-quarter profit, with consumer sentiment ...

DIMO Healthcare, DIMO’s healthcare arm, together with Siemens Healthineers, has once again demonstrated its commitment to further advancing cancer treatment in Sri Lanka by introducing the ...

The growing demand for respiratory disease testing is largely driven by the increasing global prevalence of respiratory ...

The firm reported that its adjusted diagnostics revenues rose less than 1 percent, excluding the COVID-19 rapid antigen testing business that the firm exited last year.

Only Siemens makes the simultaneous acquisition of whole-body MR and PET possible. Molecular MR supports our joint vision for healthcare – to advance disease management and improve care for all ...